Tri Locum Partners LP Axsome Therapeutics, Inc. Transaction History
Tri Locum Partners LP
- $364 Million
- Q3 2025
A detailed history of Tri Locum Partners LP transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Tri Locum Partners LP holds 292,137 shares of AXSM stock, worth $40.8 Million. This represents 9.75% of its overall portfolio holdings.
Number of Shares
292,137
Previous 157,861
85.06%
Holding current value
$40.8 Million
Previous $16.5 Million
115.3%
% of portfolio
9.75%
Previous 5.93%
Shares
12 transactions
Others Institutions Holding AXSM
# of Institutions
414Shares Held
36.8MCall Options Held
752KPut Options Held
567K-
Vanguard Group Inc Valley Forge, PA4.18MShares$584 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$461 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA1.33MShares$186 Million0.03% of portfolio
-
Rtw Investments, LP New York, NY1.12MShares$156 Million1.82% of portfolio
-
Macquarie Group LTD Australia, C31.08MShares$151 Million0.16% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $5.99B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...